SCHEMBL19620595

SCHEMBL19620595

NC1=C(OS(=O)Cc2ccccc2)C(=O)C(c2ccc(Cl)c(Cl)c2)O1

nearest known ligand 0.36

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
KCNA5 P22460 1/20 0.36
KDM4E B2RXH2 1/20 0.36
POLB P06746 1/20 0.36
MAPT P10636 1/20 0.36
SLC6A2 P23975 4/20 0.32
SLC6A3 Q01959 4/20 0.32
SLC6A4 P31645 3/20 0.32
F10 P00742 1/20 0.31
CYP1A2 P05177 1/20 0.30
CYP3A4 P08684 1/20 0.30
CYP2C19 P33261 1/20 0.30
PPARG P37231 1/20 0.30
PPARA Q07869 1/20 0.30
BACE1 P56817 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19620558 0.90 KDM4E (0.34) KDM4EPOLBMAPTSLC6A2SLC6A4
SCHEMBL20367974 0.87 MAPT (0.41) KCNA5KDM4EPOLBMAPTSLC6A3
SCHEMBL20368252 0.87 MAPT (0.39) KDM4EPOLBMAPTSLC6A3
SCHEMBL19620538 0.86 KDM4E (0.37) KDM4EPOLBMAPTCYP1A2CYP3A4
SCHEMBL19620621 0.86 MAPT (0.49) KDM4EPOLBMAPTSLC6A3CYP1A2
SCHEMBL19620645 0.84 KDM4E (0.36) KDM4EPOLBMAPTCYP1A2CYP3A4
SCHEMBL19620536 0.83 CYP1A2 (0.33) KDM4EPOLBMAPTCYP1A2CYP3A4
SCHEMBL19620692 0.83 DPP4 (0.38) KDM4EPOLBMAPTCYP1A2CYP3A4
SCHEMBL15627599 0.83 KDM4E (0.41) KDM4EPOLBMAPTSLC6A3
SCHEMBL19620602 0.83 NPSR1 (0.43) KDM4EPOLBCYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3345596-A2 INHIBITORS OF BETA-HYDROLASE FOR TREATMENT OF CANCER RHODE ISLAND HOSPITAL (US) 2018-07-11 EP disclosed
EP-2897607-B1 INHIBITORS OF BETA-HYDROLASE FOR TREATMENT OF CANCER RHODE ISLAND HOSPITAL (US) 2017-11-22 EP disclosed